POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST

  2024-11-27 |   Pages: 200+ |   Report ID: MD-R-2024-11-27-182254 |   Pharmaceuticals and Healthcare

Historical data: 2018 - 2023

Forecast period: 2024 - 2031

Quantitative units: Revenue in USD million and CAGR from 2024 to 2031

Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Point of Care Pregnancy and Fertility Testing Market

Image

1.1 SCOPE OF THE REPORT

1.2 MARKET SEGMENT ANALYSIS

1.3 REGULATORY SCENARIO BY REGION/COUNTRY

1.4 MARKET INVESTMENT SCENARIO STRATEGIC

1.5 MARKET ANALYSIS BY TYPE (USD MILLION)

1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)

2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS

  2.1.1 MARKET DRIVER ANALYSIS

  2.1.2 MARKET RESTRAINT ANALYSIS

  2.1.3 MARKET OPPORTUNITY

  2.1.4 MARKET CHALLENGES

3.1 INDUSTRY TRENDS

  3.1.1 SWOT ANALYSIS

  3.1.2 PESTEL ANALYSIS

  3.1.3 PORTER’S FIVE FORCES ANALYSIS

3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS

4.1 COVID-19 ANALYSIS

5.1 GLOBAL POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET, SALES AREA, TYPE

5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET

7.1 GLOBAL POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE (2018-2031) (USD MILLION)

8.1 GLOBAL POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

8.2 GLOBAL POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

9.1 GLOBAL POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

9.2 GLOBAL POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

10.1 GLOBAL POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)

10.2 GLOBAL POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)

11.1 NORTH AMERICA POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

11.2 NORTH AMERICA POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

11.3 NORTH AMERICA POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

11.4 NORTH AMERICA POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

11.5 NORTH AMERICA POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

11.6 NORTH AMERICA POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

12.1 EUROPE POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

12.2 EUROPE POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

12.3 EUROPE POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

12.4 EUROPE POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

12.5 EUROPE POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

12.6 EUROPE POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

13.1 ASIA PACIFIC POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

13.2 ASIA PACIFIC POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

13.3 ASIA PACIFIC POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

13.4 ASIA PACIFIC POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

13.5 ASIA PACIFIC POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

13.6 ASIA PACIFIC POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

14.1 LATIN AMERICA POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>

14.2 LATIN AMERICA POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

14.3 LATIN AMERICA POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

14.4 LATIN AMERICA POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

14.5 LATIN AMERICA POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

14.6 LATIN AMERICA POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

15.1 MIDDLE EAST & AFRICA POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

15.2 MIDDLE EAST & AFRICA POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

15.3 MIDDLE EAST & AFRICA POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

15.4 MIDDLE EAST & AFRICA POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

15.5 MIDDLE EAST & AFRICA POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

15.6 MIDDLE EAST & AFRICA POINT OF CARE PREGNANCY AND FERTILITY TESTING MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>

16.1 Alere

  16.1.1 COMPANY DETAILS

  16.1.2 FINANCIALS (USD MILLION)

  16.1.3 PRODUCT SUMMARY

  16.1.4 RECENT DEVELOPMENTS

16.2 Ani Biotech Oy

16.3 Beckman Coulter

16.4 bioMerieux

16.5 Church & Dwight

16.6 EKF

16.7 Insight Pharmaceuticals

16.8 Meridian

16.9 OPKO Health

16.10 Polymed Therapeutics

16.11 Polymedco

16.12 Quidel

16.13 Radiometer

16.14 Roche

16.15 Siemens Healthcare

16.16 Trinity

18.1 METHODOLOGY

18.2 RESEARCH DATA SOURCE

  18.2.1 SECONDARY DATA

  18.2.2 KEY DATA FROM SECONDARY

  18.2.3 PRIMARY DATA

  18.2.4 KEY DATA FROM PRIMARY

  18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS

  18.2.6 MARKET ESTIMATION

  18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH

  18.2.8 LEGAL DISCLAIMER

Market Segments

By Type

Human chorionic Gonadotropin (hcg) urine test
FSH urine test
Human chorionic Gonadotropin (hcg) blood test
Luteinizing hormone (LH) urine test

By Application

Hypermarkets & supermarkets
Gynaecology & fertility clinics
Pharmacy
Online sales
Drugstores

Companies

Alere
Ani Biotech Oy
Beckman Coulter
bioMerieux
Church & Dwight
EKF
Insight Pharmaceuticals
Meridian
OPKO Health
Polymed Therapeutics
Polymedco
Quidel
Radiometer
Roche
Siemens Healthcare
Trinity

BROWSE INDUSTRY

  1. Consumer Goods
  2. Healthcare
  3. Food & Beverage
  4. Heavy Industry
  5. Service Industries
  6. FMCG
  7. Life Sciences
  8. Technology & Media
  9. Machinery & Equipment

    WHY CHOOSE US

  •   PROACTIVE
  • We manage our resources 24/7 to identify issues and address them before they become problems.

  •   QUALITY & RELIABILITY
  • We are committed to providing reliable and highly accurate data with an excellent quality control system.

  •   GLOBAL OUTREACH
  • 6 Major regions and 40+ countries level analysis accomplished.

  •   COMPETITIVE PRICING
  • Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.